APO Research
Talk to an analyst

APO RESEARCH · REPORT

Premature Ejaculation Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Research

Premature Ejaculation Treatment Industry Research Report 2026

30 December 2025126 pages

Choose your research edition.

Industry ResearchPremature Ejaculation Treatment Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Premature Ejaculation Treatment Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Premature Ejaculation Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Premature Ejaculation Treatment Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Premature Ejaculation Treatment Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Global Premature Ejaculation Treatment includes Pfizer, Bayer, Menarini, Lilly and Johnson & Johnson, etc. Global top 5 companies hold a share over 44%.

Report Scope

This report quantifies the global Premature Ejaculation Treatment market in terms of revenue (US$ million) and, where applicable, sales volume (k Boxs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

Read the full market overview

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k Boxs) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Premature Ejaculation Treatment Market by Company

Pfizer

Bayer

Menarini

Lilly

Johnson & Johnson

GlaxoSmithKline

Hotan Uighur Pharmaceutical

Sichuan Kelun Pharmaceutical

Guangdong T&K Pharmaceutical Factory

Beijing Tongrentang

Tai Chi Group

Guangzhou Baiyunshan Pharmaceutical

Jiangxi Huiren Pharmaceutical

Jiuzhitang

Premature Ejaculation Treatment Segment by Type

Antidepressants (SSRIs)

Type 5 Phosphodiesterase Inhibitor

Local Anesthetics

Traditional Chinese Medicine

Ethnic Medicine

Premature Ejaculation Treatment Segment by Application

Human Medicine

Veterinary Drugs

Premature Ejaculation Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Premature Ejaculation Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Premature Ejaculation Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Premature Ejaculation Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Premature Ejaculation Treatment manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Premature Ejaculation Treatment by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Premature Ejaculation Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Premature Ejaculation Treatment Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Premature Ejaculation Treatment Sales (k Boxs) of Manufacturers (2021-2026) Table 7. Global Premature Ejaculation Treatment Sales Market Share by Manufacturers (2021-2026) Table 8. Global Premature Ejaculation Treatment Revenue of Manufacturers (2021-2026) Table 9. Global Premature Ejaculation Treatment Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Premature Ejaculation Treatment Average Price (USD/Box) of Manufacturers (2021-2026) Table 11. Global Premature Ejaculation Treatment Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Premature Ejaculation Treatment, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Premature Ejaculation Treatment, Product Type & Application Table 14. Global Premature Ejaculation Treatment Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Premature Ejaculation Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Pfizer Company Information Table 19. Pfizer Business Overview Table 20. Pfizer Premature Ejaculation Treatment Sales (k Boxs), Revenue (US$ Million), Price (USD/Box) and Gross Margin (2021-2026) Table 21. Pfizer Premature Ejaculation Treatment Product Portfolio Table 22. Pfizer Recent Developments Table 23. Bayer Company Information Table 24. Bayer Business Overview Table 25. Bayer Premature Ejaculation Treatment Sales (k Boxs), Revenue (US$ Million), Price (USD/Box) and Gross Margin (2021-2026) Table 26. Bayer Premature Ejaculation Treatment Product Portfolio Table 27. Bayer Recent Developments Table 28. Menarini Company Information Table 29. Menarini Business Overview Table 30. Menarini Premature Ejaculation Treatment Sales (k Boxs), Revenue (US$ Million), Price (USD/Box) and Gross Margin (2021-2026) Table 31. Menarini Premature Ejaculation Treatment Product Portfolio Table 32. Menarini Recent Developments Table 33. Lilly Company Information Table 34. Lilly Business Overview Table 35. Lilly Premature Ejaculation Treatment Sales (k Boxs), Revenue (US$ Million), Price (USD/Box) and Gross Margin (2021-2026) Table 36. Lilly Premature Ejaculation Treatment Product Portfolio Table 37. Lilly Recent Developments Table 38. Johnson & Johnson Company Information Table 39. Johnson & Johnson Business Overview Table 40. Johnson & Johnson Premature Ejaculation Treatment Sales (k Boxs), Revenue (US$ Million), Price (USD/Box) and Gross Margin (2021-2026) Table 41. Johnson & Johnson Premature Ejaculation Treatment Product Portfolio Table 42. Johnson & Johnson Recent Developments Table 43. GlaxoSmithKline Company Information Table 44. GlaxoSmithKline Business Overview Table 45. GlaxoSmithKline Premature Ejaculation Treatment Sales (k Boxs), Revenue (US$ Million), Price (USD/Box) and Gross Margin (2021-2026) Table 46. GlaxoSmithKline Premature Ejaculation Treatment Product Portfolio Table 47. GlaxoSmithKline Recent Developments Table 48. Hotan Uighur Pharmaceutical Company Information Table 49. Hotan Uighur Pharmaceutical Business Overview Table 50. Hotan Uighur Pharmaceutical Premature Ejaculation Treatment Sales (k Boxs), Revenue (US$ Million), Price (USD/Box) and Gross Margin (2021-2026) Table 51. Hotan Uighur Pharmaceutical Premature Ejaculation Treatment Product Portfolio Table 52. Hotan Uighur Pharmaceutical Recent Developments Table 53. Sichuan Kelun Pharmaceutical Company Information Table 54. Sichuan Kelun Pharmaceutical Business Overview Table 55. Sichuan Kelun Pharmaceutical Premature Ejaculation Treatment Sales (k Boxs), Revenue (US$ Million), Price (USD/Box) and Gross Margin (2021-2026) Table 56. Sichuan Kelun Pharmaceutical Premature Ejaculation Treatment Product Portfolio Table 57. Sichuan Kelun Pharmaceutical Recent Developments Table 58. Guangdong T&K Pharmaceutical Factory Company Information Table 59. Guangdong T&K Pharmaceutical Factory Business Overview Table 60. Guangdong T&K Pharmaceutical Factory Premature Ejaculation Treatment Sales (k Boxs), Revenue (US$ Million), Price (USD/Box) and Gross Margin (2021-2026) Table 61. Guangdong T&K Pharmaceutical Factory Premature Ejaculation Treatment Product Portfolio Table 62. Guangdong T&K Pharmaceutical Factory Recent Developments Table 63. Beijing Tongrentang Company Information Table 64. Beijing Tongrentang Business Overview Table 65. Beijing Tongrentang Premature Ejaculation Treatment Sales (k Boxs), Revenue (US$ Million), Price (USD/Box) and Gross Margin (2021-2026) Table 66. Beijing Tongrentang Premature Ejaculation Treatment Product Portfolio Table 67. Beijing Tongrentang Recent Developments Table 68. Tai Chi Group Company Information Table 69. Tai Chi Group Business Overview Table 70. Tai Chi Group Premature Ejaculation Treatment Sales (k Boxs), Revenue (US$ Million), Price (USD/Box) and Gross Margin (2021-2026) Table 71. Tai Chi Group Premature Ejaculation Treatment Product Portfolio Table 72. Tai Chi Group Recent Developments Table 73. Guangzhou Baiyunshan Pharmaceutical Company Information Table 74. Guangzhou Baiyunshan Pharmaceutical Business Overview Table 75. Guangzhou Baiyunshan Pharmaceutical Premature Ejaculation Treatment Sales (k Boxs), Revenue (US$ Million), Price (USD/Box) and Gross Margin (2021-2026) Table 76. Guangzhou Baiyunshan Pharmaceutical Premature Ejaculation Treatment Product Portfolio Table 77. Guangzhou Baiyunshan Pharmaceutical Recent Developments Table 78. Jiangxi Huiren Pharmaceutical Company Information Table 79. Jiangxi Huiren Pharmaceutical Business Overview Table 80. Jiangxi Huiren Pharmaceutical Premature Ejaculation Treatment Sales (k Boxs), Revenue (US$ Million), Price (USD/Box) and Gross Margin (2021-2026) Table 81. Jiangxi Huiren Pharmaceutical Premature Ejaculation Treatment Product Portfolio Table 82. Jiangxi Huiren Pharmaceutical Recent Developments Table 83. Jiuzhitang Company Information Table 84. Jiuzhitang Business Overview Table 85. Jiuzhitang Premature Ejaculation Treatment Sales (k Boxs), Revenue (US$ Million), Price (USD/Box) and Gross Margin (2021-2026) Table 86. Jiuzhitang Premature Ejaculation Treatment Product Portfolio Table 87. Jiuzhitang Recent Developments Table 88. Global Premature Ejaculation Treatment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 89. Global Premature Ejaculation Treatment Sales by Region (2021-2026) & (k Boxs) Table 90. Global Premature Ejaculation Treatment Sales Market Share by Region (2021-2026) Table 91. Global Premature Ejaculation Treatment Sales by Region (2027-2032) & (k Boxs) Table 92. Global Premature Ejaculation Treatment Sales Market Share by Region (2027-2032) Table 93. Global Premature Ejaculation Treatment Revenue by Region (2021-2026) & (US$ Million) Table 94. Global Premature Ejaculation Treatment Revenue Market Share by Region (2021-2026) Table 95. Global Premature Ejaculation Treatment Revenue by Region (2027-2032) & (US$ Million) Table 96. Global Premature Ejaculation Treatment Revenue Market Share by Region (2027-2032) Table 97. North America Premature Ejaculation Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. North America Premature Ejaculation Treatment Sales by Country (2021-2026) & (k Boxs) Table 99. North America Premature Ejaculation Treatment Sales by Country (2027-2032) & (k Boxs) Table 100. North America Premature Ejaculation Treatment Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Premature Ejaculation Treatment Revenue by Country (2027-2032) & (US$ Million) Table 102. Europe Premature Ejaculation Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Europe Premature Ejaculation Treatment Sales by Country (2021-2026) & (k Boxs) Table 104. Europe Premature Ejaculation Treatment Sales by Country (2027-2032) & (k Boxs) Table 105. Europe Premature Ejaculation Treatment Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Premature Ejaculation Treatment Revenue by Country (2027-2032) & (US$ Million) Table 107. Asia Pacific Premature Ejaculation Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Asia Pacific Premature Ejaculation Treatment Sales by Country (2021-2026) & (k Boxs) Table 109. Asia Pacific Premature Ejaculation Treatment Sales by Country (2027-2032) & (k Boxs) Table 110. Asia Pacific Premature Ejaculation Treatment Revenue by Country (2021-2026) & (US$ Million) Table 111. Asia Pacific Premature Ejaculation Treatment Revenue by Country (2027-2032) & (US$ Million) Table 112. South America Premature Ejaculation Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. South America Premature Ejaculation Treatment Sales by Country (2021-2026) & (k Boxs) Table 114. South America Premature Ejaculation Treatment Sales by Country (2027-2032) & (k Boxs) Table 115. South America Premature Ejaculation Treatment Revenue by Country (2021-2026) & (US$ Million) Table 116. South America Premature Ejaculation Treatment Revenue by Country (2027-2032) & (US$ Million) Table 117. Middle East and Africa Premature Ejaculation Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Middle East and Africa Premature Ejaculation Treatment Sales by Country (2021-2026) & (k Boxs) Table 119. Middle East and Africa Premature Ejaculation Treatment Sales by Country (2027-2032) & (k Boxs) Table 120. Middle East and Africa Premature Ejaculation Treatment Revenue by Country (2021-2026) & (US$ Million) Table 121. Middle East and Africa Premature Ejaculation Treatment Revenue by Country (2027-2032) & (US$ Million) Table 122. Global Premature Ejaculation Treatment Sales by Type (2021-2026) & (k Boxs) Table 123. Global Premature Ejaculation Treatment Sales by Type (2027-2032) & (k Boxs) Table 124. Global Premature Ejaculation Treatment Sales Market Share by Type (2021-2026) Table 125. Global Premature Ejaculation Treatment Sales Market Share by Type (2027-2032) Table 126. Global Premature Ejaculation Treatment Revenue by Type (2021-2026) & (US$ Million) Table 127. Global Premature Ejaculation Treatment Revenue by Type (2027-2032) & (US$ Million) Table 128. Global Premature Ejaculation Treatment Revenue Market Share by Type (2021-2026) Table 129. Global Premature Ejaculation Treatment Revenue Market Share by Type (2027-2032) Table 130. Global Premature Ejaculation Treatment Price by Type (2021-2026) & (USD/Box) Table 131. Global Premature Ejaculation Treatment Price by Type (2027-2032) & (USD/Box) Table 132. Global Premature Ejaculation Treatment Sales by Application (2021-2026) & (k Boxs) Table 133. Global Premature Ejaculation Treatment Sales by Application (2027-2032) & (k Boxs) Table 134. Global Premature Ejaculation Treatment Sales Market Share by Application (2021-2026) Table 135. Global Premature Ejaculation Treatment Sales Market Share by Application (2027-2032) Table 136. Global Premature Ejaculation Treatment Revenue by Application (2021-2026) & (US$ Million) Table 137. Global Premature Ejaculation Treatment Revenue by Application (2027-2032) & (US$ Million) Table 138. Global Premature Ejaculation Treatment Revenue Market Share by Application (2021-2026) Table 139. Global Premature Ejaculation Treatment Revenue Market Share by Application (2027-2032) Table 140. Global Premature Ejaculation Treatment Price by Application (2021-2026) & (USD/Box) Table 141. Global Premature Ejaculation Treatment Price by Application (2027-2032) & (USD/Box) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Premature Ejaculation Treatment Distributors List Table 145. Premature Ejaculation Treatment Customers List Table 146. Premature Ejaculation Treatment Industry Trends Table 147. Premature Ejaculation Treatment Industry Drivers Table 148. Premature Ejaculation Treatment Industry Restraints Table 149. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Premature Ejaculation Treatment Product Image Figure 5. Global Premature Ejaculation Treatment Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Premature Ejaculation Treatment Market Size (2021-2032) & (US$ Million) Figure 7. Global Premature Ejaculation Treatment Sales (2021-2032) & (k Boxs) Figure 8. Global Premature Ejaculation Treatment Average Price (USD/Box) & (2021-2032) Figure 9. Antidepressants (SSRIs) Product Image Figure 10. Type 5 Phosphodiesterase Inhibitor Product Image Figure 11. Local Anesthetics Product Image Figure 12. Traditional Chinese Medicine Product Image Figure 13. Ethnic Medicine Product Image Figure 14. Human Medicine Product Image Figure 15. Veterinary Drugs Product Image Figure 16. Global Premature Ejaculation Treatment Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Premature Ejaculation Treatment, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Premature Ejaculation Treatment Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Premature Ejaculation Treatment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Premature Ejaculation Treatment Sales by Region in 2025 Figure 22. Global Premature Ejaculation Treatment Revenue by Region in 2025 Figure 23. North America Premature Ejaculation Treatment Market Size by Country in 2025 Figure 24. North America Premature Ejaculation Treatment Sales Market Share by Country (2021-2032) Figure 25. North America Premature Ejaculation Treatment Revenue Market Share by Country (2021-2032) Figure 26. United States Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Premature Ejaculation Treatment Market Size by Country in 2025 Figure 30. Europe Premature Ejaculation Treatment Sales Market Share by Country (2021-2032) Figure 31. Europe Premature Ejaculation Treatment Revenue Market Share by Country (2021-2032) Figure 32. Germany Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Premature Ejaculation Treatment Market Size by Country in 2025 Figure 43. Asia Pacific Premature Ejaculation Treatment Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Premature Ejaculation Treatment Revenue Market Share by Country (2021-2032) Figure 45. China Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Premature Ejaculation Treatment Market Size by Country in 2025 Figure 54. South America Premature Ejaculation Treatment Sales Market Share by Country (2021-2032) Figure 55. South America Premature Ejaculation Treatment Revenue Market Share by Country (2021-2032) Figure 56. Brazil Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Premature Ejaculation Treatment Market Size by Country in 2025 Figure 60. Middle East and Africa Premature Ejaculation Treatment Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Premature Ejaculation Treatment Revenue Market Share by Country (2021-2032) Figure 62. Egypt Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Premature Ejaculation Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Premature Ejaculation Treatment Sales Market Share by Type (2021-2032) Figure 68. Global Premature Ejaculation Treatment Revenue Market Share by Type (2021-2032) Figure 69. Global Premature Ejaculation Treatment Price (USD/Box) by Type (2021-2032) Figure 70. Global Premature Ejaculation Treatment Sales Market Share by Application (2021-2032) Figure 71. Global Premature Ejaculation Treatment Revenue Market Share by Application (2021-2032) Figure 72. Global Premature Ejaculation Treatment Price (USD/Box) by Application (2021-2032) Figure 73. Premature Ejaculation Treatment Value Chain Figure 74. Premature Ejaculation Treatment Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Premature Ejaculation Treatment Industry Opportunities and Challenges

Scope & coverage.

Types
  • Antidepressants (SSRIs)
  • Type 5 Phosphodiesterase Inhibitor
  • Local Anesthetics
  • Traditional Chinese Medicine
  • Ethnic Medicine
Applications
  • Human Medicine
  • Veterinary Drugs
Companies covered
  • Pfizer
  • Bayer
  • Menarini
  • Lilly
  • Johnson & Johnson
  • GlaxoSmithKline
  • Hotan Uighur Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Guangdong T&K Pharmaceutical Factory
  • Beijing Tongrentang
  • Tai Chi Group
  • Guangzhou Baiyunshan Pharmaceutical
  • Jiangxi Huiren Pharmaceutical
  • Jiuzhitang

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Premature Ejaculation Treatment Market Size (2021-2032)
  4. 2.2.2 Global Premature Ejaculation Treatment Sales (2021-2032)
  5. 2.2.3 Global Premature Ejaculation Treatment Market Average Price (2021-2032)
  6. 2.3 Premature Ejaculation Treatment by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Antidepressants (SSRIs)
  9. 2.3.3 Type 5 Phosphodiesterase Inhibitor
  10. 2.3.4 Local Anesthetics
  11. 2.3.5 Traditional Chinese Medicine
  12. 2.3.6 Ethnic Medicine
  13. 2.4 Premature Ejaculation Treatment by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Human Medicine
  16. 2.4.3 Veterinary Drugs
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Premature Ejaculation Treatment Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Premature Ejaculation Treatment Sales (k Boxs) of Manufacturers (2021-2026)
  3. 3.3 Global Premature Ejaculation Treatment Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Premature Ejaculation Treatment Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Premature Ejaculation Treatment Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Premature Ejaculation Treatment, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Premature Ejaculation Treatment, Product Type & Application
  8. 3.8 Global Manufacturers of Premature Ejaculation Treatment, Established Date
  9. 3.9 Global Premature Ejaculation Treatment Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Pfizer
  2. 4.1.1 Pfizer Company Information
  3. 4.1.2 Pfizer Business Overview
  4. 4.1.3 Pfizer Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Pfizer Premature Ejaculation Treatment Product Portfolio
  6. 4.1.5 Pfizer Recent Developments
  7. 4.2 Bayer
  8. 4.2.1 Bayer Company Information
  9. 4.2.2 Bayer Business Overview
  10. 4.2.3 Bayer Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Bayer Premature Ejaculation Treatment Product Portfolio
  12. 4.2.5 Bayer Recent Developments
  13. 4.3 Menarini
  14. 4.3.1 Menarini Company Information
  15. 4.3.2 Menarini Business Overview
  16. 4.3.3 Menarini Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Menarini Premature Ejaculation Treatment Product Portfolio
  18. 4.3.5 Menarini Recent Developments
  19. 4.4 Lilly
  20. 4.4.1 Lilly Company Information
  21. 4.4.2 Lilly Business Overview
  22. 4.4.3 Lilly Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Lilly Premature Ejaculation Treatment Product Portfolio
  24. 4.4.5 Lilly Recent Developments
  25. 4.5 Johnson & Johnson
  26. 4.5.1 Johnson & Johnson Company Information
  27. 4.5.2 Johnson & Johnson Business Overview
  28. 4.5.3 Johnson & Johnson Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Johnson & Johnson Premature Ejaculation Treatment Product Portfolio
  30. 4.5.5 Johnson & Johnson Recent Developments
  31. 4.6 GlaxoSmithKline
  32. 4.6.1 GlaxoSmithKline Company Information
  33. 4.6.2 GlaxoSmithKline Business Overview
  34. 4.6.3 GlaxoSmithKline Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 GlaxoSmithKline Premature Ejaculation Treatment Product Portfolio
  36. 4.6.5 GlaxoSmithKline Recent Developments
  37. 4.7 Hotan Uighur Pharmaceutical
  38. 4.7.1 Hotan Uighur Pharmaceutical Company Information
  39. 4.7.2 Hotan Uighur Pharmaceutical Business Overview
  40. 4.7.3 Hotan Uighur Pharmaceutical Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Hotan Uighur Pharmaceutical Premature Ejaculation Treatment Product Portfolio
  42. 4.7.5 Hotan Uighur Pharmaceutical Recent Developments
  43. 4.8 Sichuan Kelun Pharmaceutical
  44. 4.8.1 Sichuan Kelun Pharmaceutical Company Information
  45. 4.8.2 Sichuan Kelun Pharmaceutical Business Overview
  46. 4.8.3 Sichuan Kelun Pharmaceutical Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Sichuan Kelun Pharmaceutical Premature Ejaculation Treatment Product Portfolio
  48. 4.8.5 Sichuan Kelun Pharmaceutical Recent Developments
  49. 4.9 Guangdong T&K Pharmaceutical Factory
  50. 4.9.1 Guangdong T&K Pharmaceutical Factory Company Information
  51. 4.9.2 Guangdong T&K Pharmaceutical Factory Business Overview
  52. 4.9.3 Guangdong T&K Pharmaceutical Factory Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Guangdong T&K Pharmaceutical Factory Premature Ejaculation Treatment Product Portfolio
  54. 4.9.5 Guangdong T&K Pharmaceutical Factory Recent Developments
  55. 4.10 Beijing Tongrentang
  56. 4.10.1 Beijing Tongrentang Company Information
  57. 4.10.2 Beijing Tongrentang Business Overview
  58. 4.10.3 Beijing Tongrentang Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Beijing Tongrentang Premature Ejaculation Treatment Product Portfolio
  60. 4.10.5 Beijing Tongrentang Recent Developments
  61. 4.11 Tai Chi Group
  62. 4.11.1 Tai Chi Group Company Information
  63. 4.11.2 Tai Chi Group Business Overview
  64. 4.11.3 Tai Chi Group Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Tai Chi Group Premature Ejaculation Treatment Product Portfolio
  66. 4.11.5 Tai Chi Group Recent Developments
  67. 4.12 Guangzhou Baiyunshan Pharmaceutical
  68. 4.12.1 Guangzhou Baiyunshan Pharmaceutical Company Information
  69. 4.12.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
  70. 4.12.3 Guangzhou Baiyunshan Pharmaceutical Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Guangzhou Baiyunshan Pharmaceutical Premature Ejaculation Treatment Product Portfolio
  72. 4.12.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
  73. 4.13 Jiangxi Huiren Pharmaceutical
  74. 4.13.1 Jiangxi Huiren Pharmaceutical Company Information
  75. 4.13.2 Jiangxi Huiren Pharmaceutical Business Overview
  76. 4.13.3 Jiangxi Huiren Pharmaceutical Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Jiangxi Huiren Pharmaceutical Premature Ejaculation Treatment Product Portfolio
  78. 4.13.5 Jiangxi Huiren Pharmaceutical Recent Developments
  79. 4.14 Jiuzhitang
  80. 4.14.1 Jiuzhitang Company Information
  81. 4.14.2 Jiuzhitang Business Overview
  82. 4.14.3 Jiuzhitang Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Jiuzhitang Premature Ejaculation Treatment Product Portfolio
  84. 4.14.5 Jiuzhitang Recent Developments
5 Global Premature Ejaculation Treatment Market Scenario by Region
  1. 5.1 Global Premature Ejaculation Treatment Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Premature Ejaculation Treatment Sales by Region: 2021-2032
  3. 5.2.1 Global Premature Ejaculation Treatment Sales by Region: 2021-2026
  4. 5.2.2 Global Premature Ejaculation Treatment Sales by Region: 2027-2032
  5. 5.3 Global Premature Ejaculation Treatment Revenue by Region: 2021-2032
  6. 5.3.1 Global Premature Ejaculation Treatment Revenue by Region: 2021-2026
  7. 5.3.2 Global Premature Ejaculation Treatment Revenue by Region: 2027-2032
  8. 5.4 North America Premature Ejaculation Treatment Market Facts & Figures by Country
  9. 5.4.1 North America Premature Ejaculation Treatment Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Premature Ejaculation Treatment Sales by Country (2021-2032)
  11. 5.4.3 North America Premature Ejaculation Treatment Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Premature Ejaculation Treatment Market Facts & Figures by Country
  16. 5.5.1 Europe Premature Ejaculation Treatment Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Premature Ejaculation Treatment Sales by Country (2021-2032)
  18. 5.5.3 Europe Premature Ejaculation Treatment Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Premature Ejaculation Treatment Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Premature Ejaculation Treatment Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Premature Ejaculation Treatment Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Premature Ejaculation Treatment Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Premature Ejaculation Treatment Market Facts & Figures by Country
  41. 5.7.1 South America Premature Ejaculation Treatment Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Premature Ejaculation Treatment Sales by Country (2021-2032)
  43. 5.7.3 South America Premature Ejaculation Treatment Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Premature Ejaculation Treatment Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Premature Ejaculation Treatment Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Premature Ejaculation Treatment Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Premature Ejaculation Treatment Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Premature Ejaculation Treatment Sales by Type (2021-2032)
  2. 6.1.1 Global Premature Ejaculation Treatment Sales by Type (2021-2032) & (k Boxs)
  3. 6.1.2 Global Premature Ejaculation Treatment Sales Market Share by Type (2021-2032)
  4. 6.2 Global Premature Ejaculation Treatment Revenue by Type (2021-2032)
  5. 6.2.1 Global Premature Ejaculation Treatment Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Premature Ejaculation Treatment Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Premature Ejaculation Treatment Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Premature Ejaculation Treatment Sales by Application (2021-2032)
  2. 7.1.1 Global Premature Ejaculation Treatment Sales by Application (2021-2032) & (k Boxs)
  3. 7.1.2 Global Premature Ejaculation Treatment Sales Market Share by Application (2021-2032)
  4. 7.2 Global Premature Ejaculation Treatment Revenue by Application (2021-2032)
  5. 7.2.1 Global Premature Ejaculation Treatment Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Premature Ejaculation Treatment Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Premature Ejaculation Treatment Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Premature Ejaculation Treatment Value Chain Analysis
  2. 8.1.1 Premature Ejaculation Treatment Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Premature Ejaculation Treatment Production Mode & Process
  5. 8.2 Premature Ejaculation Treatment Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Premature Ejaculation Treatment Distributors
  8. 8.2.3 Premature Ejaculation Treatment Customers
9 Global Premature Ejaculation Treatment Analyzing Market Dynamics
  1. 9.1 Premature Ejaculation Treatment Industry Trends
  2. 9.2 Premature Ejaculation Treatment Industry Drivers
  3. 9.3 Premature Ejaculation Treatment Industry Opportunities and Challenges
  4. 9.4 Premature Ejaculation Treatment Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst